Endoscopic procedures in dysphagia assessed in Swedish Skåne Region in August 2019

12

Sep 2019

In Sweden, the County Councils are grouped into six healthcare regions to facilitate cooperation and to maintain a high level of advanced medical care. One of them is the Priority Council of Skåne Region established in 2015, which has a long-term mission to oversee the use of drugs and medical methods in the region, as well as managing individual cases. Its role in relation to market access is to prepare and present suggestions for new methods, routines, and treatments, to be included in the healthcare system, to the Regional Executive Board.

In August 2019, the Priority Council of Skane Region has published a health technology assessment opinion for fiberoptic endoscopic evaluation of swallowing (FEES) and videofluoroscopy (VFS) in the diagnosis of dysphagia, which describes the evidence base of these procedures in patients with dysphagia in Region Skåne. The following conclusions were provided:

  • The analysis has shown that in accordance with comprehensive scientific literature, VFS and FEES are clinically well-established procedures. However, there are no studies that shown that the use of VFS or FEES in dysphagia lead to significant patient benefit or other added value. The evaluation of the diagnostic precision of the methods is also difficult due to the absence of an established definition of disease
  • The analysis has shown that there are several medium or high-quality diagnostic studies, which shown that both procedures have good and equal coherence between different assessors and in repeated assessments
  • It was also stated that the study of dysphagia in Region Skåne is divided into several business areas. In that case, the establishment of one multidisciplinary center could improve patient flows and provide unique care.

See the full information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more